Literature DB >> 32430976

Artificial Intelligence during a pandemic: The COVID-19 example.

Sathian Dananjayan1, Gerard Marshall Raj2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32430976      PMCID: PMC7276785          DOI: 10.1002/hpm.2987

Source DB:  PubMed          Journal:  Int J Health Plann Manage        ISSN: 0749-6753


× No keyword cloud information.
Artificial intelligence (AI) is transforming our lifestyle intending to mimic human intelligence by a computer/machine in solving various issues. Initially, AI was designed to overcome simpler problems like winning a chess game, language recognition, image retrieval, among others. With the technological advancements, AI is getting increasingly sophisticated at doing what humans do, but more efficiently, rapidly, and at a lower cost in solving complex problems. AI in healthcare provides an upper hand undoubtedly over traditional analytics and clinical decision‐making techniques. Machine learning (ML) algorithms, a subset of AI, can detect patterns from huge complex datasets to become more precise and accurate as they interact with training data, allowing humans to gain unprecedented insights into early detection of diseases, drug discovery, diagnostics, healthcare processes, treatment variability, and patient outcomes. But how effective are the AI algorithms during a disease outbreak or for that matter a pandemic? After 2000, the pandemics are testing the AI's ability to handle extreme events. The two major factors affecting AI algorithms include the availability of historical and real‐time data and high computational power. The different roles played by AI during pandemics are early warning and alerts, prediction and detection of outbreak of diseases, real‐time disease monitoring worldwide, analysis and visualisation of spreading trends, prediction of infection rate and infection trend, rapid decision‐making to identify the effective treatments, study and analysis of the pathogens, and drug discovery. All these are executed at a greater speed with AI. WHO and CDC (United States) are receiving data of several diseases and situations occurring across the world. With modern computer architecture and internet, all these data can be accessed in real‐time by different institutes to develop an autonomous or collaborative AI model to handle various tasks. In addition to the official data, AI can gather information from news outlets, forums, healthcare reports, travel data, social media posts, and others in multiple languages across the world by using natural language processing (NLP) techniques and flag their priority. Several terabytes of data which includes patients' case history, geographical events, and social media posts about a new pneumonia are processed at a rapid rate with high‐performance computing to predict the possible outbreak of a pandemic. , , Most importantly unsupervised ML can identify its own pattern from the noise (historical and real‐time data) rather than the training it on a preselected dataset, thus giving a wider possibility and new behaviour. An AI model trained to predict a particular disease can be retrained on the new data of a new or different disease. Some noticeable examples of AI that are used to battle the COVID‐19 pandemic and others are as follows: AI can be used as an early outbreak warning system, BlueDot, an AI‐driven algorithm not only successfully detected the outbreak of Zika virus in Florida but also spotted COVID‐19, 9 days before the WHO released its statement alerting people to the emergence of a novel coronavirus. Researchers from the Huazhong University of Science and Technology (HUST) and Tongji Hospital in Wuhan, Hubei have developed an AI diagnostic tool (XGBoost machine learning‐based prognostic model) that can quickly analyse blood samples to predict survival rates of COVID‐19 infected patients and it turns out to be 90% accurate. In Wuhan, China, an AI diagnostic tool is used to distinguish COVID‐19 from other types of pneumonia within seconds by analysing patients' chest CT scan images. The authors claimed that their new model holds great potential to relieve the pressure off frontline radiologists, improve early diagnosis, isolation and treatment, and thus contribute to the control of the epidemic. COVID‐Net, a deep learning model is designed to detect the COVID‐19 positive cases from chest X‐rays and accelerate treatment for those who need it the most. Google's DeepMind is helping scientist to study various features of the SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus 2) and has predicted the protein structure of the virus. Several AI‐based computer vision camera systems are deployed in China and across the world to scan crowds for COVID‐19 symptoms and monitor people during lockdown. FluSense, a contactless syndromic surveillance platform, is used to forecast seasonal flu and other viral respiratory outbreaks, such as the COVID‐19 pandemic or SARS. Interestingly, AI‐powered autonomous service robots and humanoid robots “Cloud Ginger (aka XR‐1)” are used in hospitals at Wuhan, China. The first is used to assist the healthcare workers to deliver the foods and medicines to the patients and the latter is used to entertain the patients during quarantine. There are also few AI models that are a hit and miss due to lack of historical training data. Though AI has not completely evolved to overcome a pandemic, but the role of AI is noticeably high during COVID‐19 when compared to that of previous pandemics and is rightly used as a tool complementing the human intelligence.

CONFLICT OF INTEREST

The authors declare no conflicts of interest.
  5 in total

1.  How Artificial Intelligence Will Change Medicine.

Authors:  Claudia Wallis
Journal:  Nature       Date:  2019-12       Impact factor: 49.962

Review 2.  Artificial intelligence in medicine.

Authors:  Pavel Hamet; Johanne Tremblay
Journal:  Metabolism       Date:  2017-01-11       Impact factor: 8.694

3.  Anticipating the international spread of Zika virus from Brazil.

Authors:  Isaac I Bogoch; Oliver J Brady; Moritz U G Kraemer; Matthew German; Marisa I Creatore; Manisha A Kulkarni; John S Brownstein; Sumiko R Mekaru; Simon I Hay; Emily Groot; Alexander Watts; Kamran Khan
Journal:  Lancet       Date:  2016-01-15       Impact factor: 79.321

Review 4.  Artificial intelligence in healthcare: past, present and future.

Authors:  Fei Jiang; Yong Jiang; Hui Zhi; Yi Dong; Hao Li; Sufeng Ma; Yilong Wang; Qiang Dong; Haipeng Shen; Yongjun Wang
Journal:  Stroke Vasc Neurol       Date:  2017-06-21

5.  Deep learning-based model for detecting 2019 novel coronavirus pneumonia on high-resolution computed tomography.

Authors:  Jun Chen; Lianlian Wu; Jun Zhang; Liang Zhang; Dexin Gong; Yilin Zhao; Qiuxiang Chen; Shulan Huang; Ming Yang; Xiao Yang; Shan Hu; Yonggui Wang; Xiao Hu; Biqing Zheng; Kuo Zhang; Huiling Wu; Zehua Dong; Youming Xu; Yijie Zhu; Xi Chen; Mengjiao Zhang; Lilei Yu; Fan Cheng; Honggang Yu
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

  5 in total
  9 in total

1.  Artificial Intelligence and Machine Learning in Cancer Research: A Systematic and Thematic Analysis of the Top 100 Cited Articles Indexed in Scopus Database.

Authors:  Ibrahim H Musa; Lukman O Afolabi; Ibrahim Zamit; Taha H Musa; Hassan H Musa; Andrew Tassang; Tosin Y Akintunde; Wei Li
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

Review 2.  Artificial Intelligence and technology in COVID Era: A narrative review.

Authors:  Vanita Ahuja; Lekshmi V Nair
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2021-04-10

3.  Machine learning is the key to diagnose COVID-19: a proof-of-concept study.

Authors:  Cedric Gangloff; Sonia Rafi; Guillaume Bouzillé; Louis Soulat; Marc Cuggia
Journal:  Sci Rep       Date:  2021-03-30       Impact factor: 4.379

4.  Early survey with bibliometric analysis on machine learning approaches in controlling COVID-19 outbreaks.

Authors:  Haruna Chiroma; Absalom E Ezugwu; Fatsuma Jauro; Mohammed A Al-Garadi; Idris N Abdullahi; Liyana Shuib
Journal:  PeerJ Comput Sci       Date:  2020-11-23

5.  Blockchain and AI-Based Solutions to Combat Coronavirus (COVID-19)-Like Epidemics: A Survey.

Authors:  Dinh C Nguyen; Ming Ding; Pubudu N Pathirana; Aruna Seneviratne
Journal:  IEEE Access       Date:  2021-06-30       Impact factor: 3.367

Review 6.  AI for COVID-19 Detection from Radiographs: Incisive Analysis of State of the Art Techniques, Key Challenges and Future Directions.

Authors:  R Karthik; R Menaka; M Hariharan; G S Kathiresan
Journal:  Ing Rech Biomed       Date:  2021-07-26

Review 7.  Viral outbreaks detection and surveillance using wastewater-based epidemiology, viral air sampling, and machine learning techniques: A comprehensive review and outlook.

Authors:  Omar M Abdeldayem; Areeg M Dabbish; Mahmoud M Habashy; Mohamed K Mostafa; Mohamed Elhefnawy; Lobna Amin; Eslam G Al-Sakkari; Ahmed Ragab; Eldon R Rene
Journal:  Sci Total Environ       Date:  2021-08-21       Impact factor: 7.963

8.  Analyzing the impact of machine learning and artificial intelligence and its effect on management of lung cancer detection in covid-19 pandemic.

Authors:  Raja Sarath Kumar Boddu; Partha Karmakar; Ankan Bhaumik; Vinay Kumar Nassa; Sumanta Bhattacharya
Journal:  Mater Today Proc       Date:  2021-12-03

9.  Intelligent IoT (IIoT) Device to Identifying Suspected COVID-19 Infections Using Sensor Fusion Algorithm and Real-Time Mask Detection Based on the Enhanced MobileNetV2 Model.

Authors:  Rupali Kiran Shinde; Md Shahinur Alam; Seong Gyoon Park; Sang Myeong Park; Nam Kim
Journal:  Healthcare (Basel)       Date:  2022-02-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.